Monoclonal antibody to HLA-A3
- PMID: 6208124
- DOI: 10.1089/hyb.1.1982.1.87
Monoclonal antibody to HLA-A3
Abstract
The monoclonal antibody GAP A3 detects the HLA allospecificity A3. Reactivity of the monoclonal was in exact concordance with the presence of the A3 antigen as defined by conventional alloantisera on a panel of 59 cells from individuals with well-characterized HLA antigens. Reactivity with GAP A3 segregated with HLA-A3 in a family where three of eight siblings inherited the paternal A3 antigen. GAP A3 precipitated appropriate 44,000- and 12,000-dalton bands on SDS-polyacrylamide gels under reducing conditions from an HLA-A3-positive, but not an HLA-A3-negative B lymphoblastoid cell line. Thus, by serological, familial, and biochemical criteria, GAP A3 defines the allospecificity HLA-A3.
Similar articles
-
Monoclonal antibody to a supertypic determinant associated with HLA-DRw52.Hybridoma. 1989 Aug;8(4):467-74. doi: 10.1089/hyb.1989.8.467. Hybridoma. 1989. PMID: 2476377
-
A cytotoxic anti-HLA-AB monoclonal antibody which in dilution becomes specific to HLA-A3 crossreacting group.Tissue Antigens. 1984 Aug;24(2):107-12. doi: 10.1111/j.1399-0039.1984.tb02113.x. Tissue Antigens. 1984. PMID: 6208633
-
A mouse monoclonal antibody detecting the allospecificity HLA-A3.Tissue Antigens. 1984 Jan;23(1):12-6. doi: 10.1111/j.1399-0039.1984.tb00002.x. Tissue Antigens. 1984. PMID: 6608163
-
The antibody response to an HLA mismatch: a model for nonself-self discrimination in relation to HLA epitope immunogenicity.Int J Immunogenet. 2012 Feb;39(1):1-9. doi: 10.1111/j.1744-313X.2011.01042.x. Epub 2011 Oct 10. Int J Immunogenet. 2012. PMID: 21981757 Review.
-
Monoclonal antibodies to HLA determinants.Br Med Bull. 1984 Jul;40(3):267-75. doi: 10.1093/oxfordjournals.bmb.a071988. Br Med Bull. 1984. PMID: 6205714 Review. No abstract available.
Cited by
-
Golgi targeting of human guanylate-binding protein-1 requires nucleotide binding, isoprenylation, and an IFN-gamma-inducible cofactor.Proc Natl Acad Sci U S A. 2005 Jun 14;102(24):8680-5. doi: 10.1073/pnas.0503227102. Epub 2005 Jun 3. Proc Natl Acad Sci U S A. 2005. PMID: 15937107 Free PMC article.
-
HLA-DM interactions with intermediates in HLA-DR maturation and a role for HLA-DM in stabilizing empty HLA-DR molecules.J Exp Med. 1996 Dec 1;184(6):2153-65. doi: 10.1084/jem.184.6.2153. J Exp Med. 1996. PMID: 8976171 Free PMC article.
-
A combined immunopeptidomics, proteomics, and cell surface proteomics approach to identify immunotherapy targets for diffuse intrinsic pontine glioma.Front Oncol. 2023 Aug 11;13:1192448. doi: 10.3389/fonc.2023.1192448. eCollection 2023. Front Oncol. 2023. PMID: 37637064 Free PMC article.
-
Treatment of ovarian cancer cell lines with 5-aza-2'-deoxycytidine upregulates the expression of cancer-testis antigens and class I major histocompatibility complex-encoded molecules.Cancer Immunol Immunother. 2009 Apr;58(4):589-601. doi: 10.1007/s00262-008-0582-6. Epub 2008 Sep 13. Cancer Immunol Immunother. 2009. PMID: 18791715 Free PMC article.
-
Targeting loss of heterozygosity for cancer-specific immunotherapy.Proc Natl Acad Sci U S A. 2021 Mar 23;118(12):e2022410118. doi: 10.1073/pnas.2022410118. Proc Natl Acad Sci U S A. 2021. PMID: 33731480 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous